X-Ray Crystallography of Carbonic Anhydrase Inhibitors and Its Importance in Drug Design (426 views)
Drug Des Of Zinc Enzyme Inhibitors (ISSN: 9780-4702, 9780-470275009), 2009; N/D: 73-138.
Export to BibTeX Export to EndNote
Paper type: Book Chapter,
Impact factor: 1.156, 5-year impact factor: 1.164
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84889476926&partnerID=40&md5=100abd98c45819e211516e4c1d515574
Keywords: Three-Dimensional Structures Of Hca Ii Inhibitor Complexes, X-Ray Crystallography Of Cais And Importance In Drug Design, Zinc Binding Group (zbg), Organic Scaffold And, Tails, In Potent Cai,
Affiliations:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini-CNR, Via Mezzocannone 16, 80134 Naples, Italy
Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Polo Scientifico, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence), Italy
References:
Maren, T.H., Carbonic anhydrase: chemistry, physiology and inhibition (1967) Physiol. Rev, 47, pp. 595-78
Supuran, C.T., Scozzafava, A., Conway, J., Carbonic Anhydrase: Its Inhibitors and Activators (2004), pp. 1-363. , CRC Press: Boca RatonSupuran, C.T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat. Rev. Drug Discov, 7, pp. 168-181
Lehtonen, J.M., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C.T., Parkkila, A.-K., Parkkila, S., Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family (2004) J. Biol. Chem, 279, pp. 2719-2727
Köhler, K., Hillebrecht, A., SchulzeWischeler, J., Innocenti, A., Heine, A., Supuran, C.T., Klebe, G., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew. Chem. Int. Ed. Engl, 46, pp. 7697-7699
Pastorekova, S., Parkkila, S., Pastorek, J., Supuran, C.T., Carbonic anhydrases: current state of the art, therapeutic applications and future prospects (2004) J. Enzyme Inhib. Med. Chem, 19, pp. 199-229
Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Modulation of carbonic anhydrase activity and its applications in therapy (2004) Expert Opin. Ther. Pat, 14, pp. 667-702
Winum, J.-Y., Scozzafava, A., Montero, J.-L., Supuran, C.T., Newzinc bindingmotifs inthe design of selective carbonic anhydrase inhibitors (2006) Bioorg. Med. Chem, 6, pp. 921-936
Hilvo, M., Rafajová, M., Pastoreková, S., Pastorek, J., Parkkila, S., Expression of carbonic anhydrase IX in mouse tissues (2004) J.Histochem.Cytochem, 52, pp. 1313-1322
Kaunisto, K., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J., Sly, W.S., Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification (2002) Kidney Int, 61, pp. 2111-2118
Kyllönen, M.S., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J.H., Shah, G.N., Sly, W.S., Kaunisto, K., Localization of carbonic anhydrase XII to the basolateral membrane of H{thorn}-secreting cells of mouse and rat kidney (2003) J. Histochem. Cytochem, 51, pp. 1217-1224
Menchise, V., De Simone, G., Alterio, V., Di Fiore, A., Pedone, C., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (2005) J. Med. Chem, 48, pp. 5721-5727
Weber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C.T., Scozzafava, A., Klebe, G., Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: newpharmacological opportunities due to related binding site recognition (2004) J. Med. Chem, 47, pp. 550-557
Abbate, F., Casini, A., Owa, T., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX (2004) Bioorg. Med. Chem. Lett, 14, pp. 217-223
Alterio, V., Vitale, R.M., Monti, S.M., Pedone, C., Scozzafava, A., Cecchi, A., De Simone, G., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J. Am. Chem. Soc, 128, pp. 8329-8335
Alterio, V., De Simone, G., Monti, S.M., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides-solution and crystallographic studies (2007) Bioorg. Med. Chem. Lett, 17, pp. 4201-4207
De Simone, G., Di Fiore, A., Menchise, V., Pedone, C., Antel, J., Casini, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies (2005) Bioorg. Med. Chem. Lett, 15, pp. 2315-2320
Boriack, P.A., Christianson, D.W., Kingery-Wood, J., Whitesides, G.M., Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants (1995) J. Med. Chem, 38, pp. 2286-2291
Casini, A., Antel, J., Abbate, F., Scozzafava, A., David, S., Waldeck, H., Schafer, S., Supuran, C.T., Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV (2003) Bioorg. Med. Chem. Lett, 13, pp. 841-845
Kim, C.-Y., Chang, J.S., Doyon, J.B., Baird, T.T., Fierke, C.A., Jain, A., Christianson, D.W., Contribution of fluorine to protein-ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II (2000) J. Am. Chem. Soc, 122, pp. 12125-12134
Smith, G.M., Alexander, R.S., Christianson, D.W., McKeever, B.M., Ponticello, G.S., Springer, J.P., Randall, W.C., Habecker, C.N., Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors (1994) Protein Sci, 3, pp. 118-125
Stams, T., Chen, Y., Boriack-Sjodin, P.A., Hurt, J.D., Liao, J., May, J.A., Dean, T., Christianson, D.W., Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination (1998) Protein Sci, 7, pp. 556-563
Whittington, D.A., Waheed, A., Ulmasov, B., Shah, G.N., Grubb, J.H., Sly, W.S., Christianson, D.W., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 9545-9550
Kannan, K.K., Ramanadham, M., Jones, T.A., Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I (1984) Ann. N.Y. Acad. Sci, 429, pp. 49-60
Eriksson, A.E., Jones, T.A., Liljas, A., Refined structure of human carbonic anhydrase II at 2.0 Å resolution (1988) Proteins, 4, pp. 274-282
Eriksson, A.E., Liljas, A., Refined structure of bovine carbonic anhydrase III at 2.0 Å resolution (1993) Proteins, 16, pp. 29-42
Duda, D.M., Tu, C., Fisher, S.Z., An, H., Yoshioka, C., Govindasamy, L., Laipis, P.J., McKenna, R., Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer (2005) Biochemistry, 44, pp. 10046-10053
Stams, T., Nair, S.K., Okuyama, T., Waheed, A., Sly, W.S., Christianson, D.W., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IVat 2.8 Å resolution (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 13589-13594
Di Fiore, A., Monti, S.M., Hilvo, M., Parkkila, S., Romano, V., Scaloni, A., Pedone, C., De Simone, G., Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide (2008) Proteins, 74, pp. 164-175
Håkansson, K., Carlsson, M., Svensson, L.A., Liljas, A., Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes (1992) J. Mol. Biol, 227, pp. 1192-1204
Stams, T., Christianson, D.W., X-ray crystallographic studies of mammalian carbonic anhydrase isozymes (2000), pp. 159-174. , In The Carbonic Anhydrases: New Horizons
Birkhäuser Verlag: Basel, SwitzerlandChristianson, D.W., Fierke, C.A., Carbonic anhydrase: evolution of the zinc binding site by nature and by design (1996) Acc. Chem. Res, 29, pp. 331-339
Lindskog, S., Structure and mechanism of carbonic anhydrase (1997) Pharmacol. Ther, 74, pp. 1-20
Lindskog, S., Silverman, D.W., The catalytic mechanism of mammalian carbonic anhydrases (2000), pp. 175-195. , In The Carbonic Anhydrases: New Horizons
Temperini, C., El Cheikh, K., Innocenti, A., Vullo, D., Ciattini, S., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue (2006) J. Med. Chem, 49, pp. 7024-7031
Güzel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C.T., Carbonic anhydrase inhibitors: interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 152-158
Casini, A., Abbate, F., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: Xray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamidetwo heads are better than one? Bioorg (2003) Med. Chem. Lett, 13, pp. 2759-2763
Liljas, A., Håkansson, K., Jonsson, B.H., Xue, Y., Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses (1994) Eur. J. Biochem, 219, pp. 1-10
Thiry, A., Dogné, J.M., Supuran, C.T., Masereel, B., Anticonvulsant sulfonamides/ sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action (2008) Curr. Pharm. Des, 14, pp. 661-671
Briganti, F., Mangani, S., Scozzafava, A., Vernaglione, G., Supuran, C.T., Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction? J (1999) Biol. Inorg. Chem, 4, pp. 528-536
Guerri, A., Briganti, F., Scozzafava, A., Supuran, C.T., Mangani, S., Mechanism of cyanamide hydration catalyzed by carbonic anhydrase II suggested by cryogenic X-ray diffraction (2000) Biochemistry, 39, pp. 12391-12397
Scolnick, L.R., Clements, A.M., Liao, J., Crenshaw, L., Hellberg, M., May, J., Dean, T.R., Christianson, D.W., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J. Am. Chem. Soc, 119, pp. 850-851
Mangani, S., Håkansson, K., Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulfide and nitrate anions (1992) Eur. J. Biochem., 210, pp. 867-871
Jönsson, B.M., Håkansson, K., Liljas, A., The structure of human carbonic anhydrase II in complex with bromide and azide (1992) FEBS Lett, 322, pp. 186-190
Nair, S.K., Christianson, D.W., Crystallographic studies of azide binding to human carbonic anhydrase II (1993) Eur. J. Biochem, 213, pp. 507-515
Eriksson, A.E., Kylsten, P.M., Jones, T.A., Liljas, A., Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high pH (1983) Proteins, 4, pp. 283-293
Lindahl, M., Svensson, L.A., Liljas, A., Metal poison inhibition of carbonic anhydrase (1993) Proteins, 15, pp. 177-182
Keilin, D., Mann, T., Carbonic anhydrase. Purification and nature of the enzyme (1940) Biochem. J, 34, pp. 1163-1176
Clare, B.W., Supuran, C.T., A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors (2006) Expert Opin. Drug Metab. Toxicol, 2, pp. 113-137
Temperini, C., Scozzafava, A., Supuran, C.T., Carbonic anhydrase activation and the drug design (2008) Curr. Pharm. Des, 14, pp. 708-715
King, R.W., Burgen, A.S., Sulfonamide complexes of human carbonic anhydrases. Ultraviolet difference spectroscopy (1970) Biochim. Biophys. Acta, 207, pp. 278-285
Lindahl, M., Vidgren, J., Eriksson, E., Habash, J., Harrop, S., Helliwell, J., Liljas, A., Walker, N., Crystallographic studies of carbonic anhydrase inhibition (1991), pp. 111-118. , In Carbonic Anhydrase: From Biochemistry and Genetics to Physiology and Clinical Medicine
VCH: Weinheim, GermanyAbbate, F., Supuran, C.T., Scozzafava, A., Orioli, P., Stubbs, M.T., Klebe, G., Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design (2002) J. Med. Chem, 45, pp. 3583-3587
Beasley, Y.M., Overell, B.G., Petrow, V., Stephenson, O., Some in vitro inhibitors of carbonic anhydrase (1958) J. Pharm. Pharmacol, 10, pp. 696-705
Helicon Press: Timisoara, RomaniaMincione, F., Starnotti, M., Menabuoni, L., Scozzafava, A., Casini, A., Supuran, C.T., Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl- benzenecarboxamides with strong topical antiglaucoma properties (2001) Bioorg. Med. Chem. Lett, 11, pp. 1787-1791
Jain, A., Whitesides, G.M., Alexander, R.S., Christianson, D.W., Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solutionphase and solid-state studies and their use in the development of tight-binding inhibitors (1994) J. Med. Chem, 37, pp. 2100-2105
Avila, L.Z., Chu, Y.H., Blossey, E.C., Whitesides, G.M., Use of affinity capillary electrophoresis to determine kinetic and equilibrium constants for binding of arylsulfonamides to bovine carbonic anhydrase (1993) J. Med. Chem, 36, pp. 126-133
Gao, J., Qiao, S., Whitesides, G.M., Increasing binding constants of ligands to carbonic anhydrase by using ''greasy tails'' (1995) J. Med. Chem, 38, pp. 2292-2301
Gao, J., Cheng, X., Chen, R., Sigal, G.B., Bruce, J.E., Schwartz, B.L., Hofstadler, S.A., Whiteside, G.M., Screening derivatized peptide libraries for tight binding inhibitors to carbonic anhydrase II by electrospray ionization-mass spectrometry (1996) J. Med.Chem, 39, pp. 1949-1955
Jude, K.M., Banerjee, A.L., Haldar, M.K., Manokaran, S., Roy, B., Mallik, S., Srivastava, D.K., Christianson, D.W., Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with two-prong inhibitors reveal the molecular basis of high affinity (2006) J. Am. Chem. Soc, 128, pp. 3011-3018
Roy, B.C., Banerjee, A.L., Swanson, M., Jia, X.G., Haldar, M.K., Mallik, S., Srivastava, D.K., Two-prong inhibitors for human carbonic anhydrase II (2004) J. Am. Chem. Soc, 126, pp. 13206-13207
Doyon, J.B., Jain, A., The pattern of fluorine substitution affects binding affinity in a small library of fluoroaromatic inhibitors for carbonic anhydrase (1999) Org. Lett, 1, pp. 183-185
Cappalonga Bunn, A.M., Alexander, R.S., Christianson, D.W., Mapping protein-peptide affinity: binding of peptidylsulfonamide inhibitors to human carbonic anhydrase II (1994) J. Am. Chem. Soc, 116, pp. 5063-5068
Jain, A., Huang, S.G., Whitesides, G.M., Lack of effect of the length of oligoglycine- and oligo(ethy1ene glycol)-derived para-substituents on the amnity of benzenesulfonamides for carbonic anhydrase II in solution (1994) J. Am. Chem. Soc, 116, pp. 5057-5062
Taylor, P.W., King, R.W., Burgen, A.S.V., Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides (1970) Biochemistry, 9, pp. 2638-2645
Cecchi, A., Winum, J.-Y., Innocenti, A., Vullo, D., Montero, J.-L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/ tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide (2004) Bioorg. Med. Chem. Lett, 14, pp. 5775-5780
Innocenti, A., Casini, A., Alcaro, M.C., Papini, A.M., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library (2004) J. Med. Chem, 47, pp. 5224-5229
Di Fiore, A., De Simone, G., Menchise, V., Pedone, C., Casini, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II (2005) Bioorg. Med. Chem. Lett, 15, pp. 1937-1942
Svastová, E., Hulíková, A., Rafajová, M., Zat'ovicová, M., Gibadulinová, A., Casini, A., Cecchi, A., Pastoreková, S., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Cecchi, A., Hulikova, A., Pastorek, J., Pastoreková, S., Scozzafava, A., Winum, J.Y., Montero, J.L., Supuran, C.T., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J. Med. Chem, 48, pp. 4834-4841
Pastorekova, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., Supuran, C.T., Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg. Med. Chem. Lett, 14, pp. 869-873
Scozzafava, A., Briganti, F., Ilies, M.A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes (2000) J. Med. Chem, 43, pp. 292-300
Casey, J.R., Morgan, P.E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J. Med. Chem, 47, pp. 2337-2347
Balaban, A.T., Dinculescu, A., Dorofeenko, G.N., Fischer, G.W., Koblik, A.V., Mezheritskii, V.V., Schroth, W., Pyrylium salts: syntheses, reactions and physical properties (1982), pp. 8-360. , In Advances in Heterocyclic Chemistry
Katritzky, A. R., Ed.
Academic Press: New YorkSupuran, C.T., Manole, G., Dinculescu, A., Schiketanz, A., Gheorghiu, M.D., Puscas, I., Balaban, A.T., Carbonic anhydrase inhibitors. V: Pyrylium salts in the synthesis of isozyme-specific inhibitors (1992) J. Pharm. Sci, 81, pp. 716-719
Srivastava, D.K., Jude, K.M., Banerjee, A.L., Haldar, M., Manokaran, S., Kooren, J., Mallik, S., Christianson, D.W., Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II (2007) J. Am. Chem. Soc, 129, pp. 5528-5537
Kim, C.Y., Chandra, P.P., Jain, A., Christianson, D.W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J. Am. Chem. Soc, 123, pp. 9620-9627
May, J.A., Namil, A., Chen, H.H., Dantanarayana, A.P., Dupré, B., Liao, J.C., Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: potential membrane-impermeable inhibitors of carbonic anhydrase (2006) Bioorg. Med. Chem, 14, pp. 2052-2059
Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors (2005) J. Med. Chem., 48, p. 7860
Vullo, D., Franchi, M., Gallori, E., Pastorek, J., Scozzafava, A., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (2003) Bioorg. Med. Chem. Lett, 13, pp. 1005-1009
Winum, J.Y., Dogné, J.M., Casini, A., De Leval, X., Montero, J.L., Scozzafava, A., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties (2005) J. Med. Chem, 48, pp. 2121-2125
Abbate, F., Coetzee, A., Casini, A., Ciattini, S., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride (2004) Bioorg. Med. Chem. Lett, 14, pp. 337-341
Chakravarty, S., Kannan, K.K., Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme (1994) J. Mol. Biol, 243, pp. 298-309
Vidgren, J., Liljas, A., Walker, N.P.C., Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 Å (1990) Int. J. Biol. Macromol, 12, pp. 342-344
Denny, W.A., Tumor-activated prodrugs. A new approach to cancer therapy (2004) Cancer Invest, 22, pp. 604-619
De Simone, G., Vitale, R.M., Di Fiore, A., Pedone, C., Scozzafava, A., Montero, J.-L., Winum, J.-Y., Supuran, C.T., Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J. Med. Chem, 49, pp. 5544-5551
D'Ambrosio, K., Vitale, R.M., Dogne, J.M., Masereel, B., Innocenti, A., Scozzafava, A., De Simone, G., Supuran, C.T., Carbonic anhydrase inhibitors: bioreductive nitrocontaining sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII (2008) J. Med. Chem, 51, pp. 3230-3237
Saczewski, F., Sławinski, J., Kornicka, A., Brzozowski, Z., Pomarnacka, E., Innocenti, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors (2006) Bioorg. Med. Chem. Lett, 16, pp. 4846-4851
Hanson, J., Dogné, J.M., Ghiotto, J., Moray, A.L., Kinsella, B.T., Pirotte, B., Design, synthesis, and SAR study of a series of N-alkyl-N0-[2-(aryloxy)-5-nitrobenzenesulfonyl] ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor (2007) J. Med. Chem, 50, pp. 3928-3936
FitzGerald, G.A., Patrono, C., The coxibs, selective inhibitors of cyclooxygenase-2 (2001) N. Engl. J. Med, 345, pp. 433-442
Davemport, H.W., The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide (1945) J. Biol. Chem, 158, pp. 567-571
Roblin Jr., R.O., Clapp, J.W., The preparation of heterocyclic sulfonamides (1950) J. Am. Chem. Soc, 72, pp. 4890-4892
Miller, W.H., Dessert, A.M., Roblin Jr., R.O., Heterocyclic sulfonamides as carbonic anhydrase inhibitors (1950) J. Am. Chem. Soc, 72, pp. 4893-4896
Barnish, I.T., Cross, P.E., Dickinson, R.P., Parry, M.J., Randall, M.J., Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides (1981) J. Med. Chem, 24, pp. 959-964
Maren, T.H., The development of topical carbonic anhydrase inhibitors (1995) J. Glaucoma, 4, pp. 49-62
Vaughan, J.R., Eichler, J.A., Anderson, G.W., Heterocyclic sulfonamides as carbonic anhydrase inhibitors, 2-acylamino and 2-sulfonamido-1,3,4-thiadiazole-5-sulfonamides (1956) J. Org. Chem, 21, pp. 700-771
Young, R.W., Wood, K.H., Vaughan, J.R., Anderson, G.W., 1,3,4-Thiadiazole and thiadiazolinesulfonamides as carbonic anhydrase inhibitors. Synthesis and structural studies (1956) J. Am. Chem. Soc, 78, pp. 4649-4654
Supuran, C.T., Ilies, M.A., Scozzafava, A., Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives (1998) Eur. J. Med. Chem, 33, pp. 739-752
Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/ heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action (2000) J. Med. Chem, 43, pp. 4542-4551
Ilies, M.A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M.T., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J. Med. Chem, 46, pp. 2187-2196
Chow, K., Lai, R., Holmes, J.M., Wijono, M., Wheeler, L.A., Garst, M.E., 5-Substituted 3-thiopenesulfonamides as carbonic anhydrase inhibitors (1996) Eur. J. Med. Chem, 31, pp. 175-186
Kim, C.Y., Whittington, D.A., Chang, J.S., Liao, J., May, J.A., Christianson, D.W., Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV (2002) J. Med. Chem, 45, pp. 888-893
Nishimori, I., Minakuchi, T., Onishi, S., Vullo, D., Cecchi, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides (2007) Bioorg. Med. Chem, 15, pp. 7229-7236
D'Ambrosio, K., Masereel, B., Thiry, A., Scozzafava, A., Supuran, C.T., De Simone, G., Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human isoform II (2008) Chem. Med. Chem, 3, pp. 473-477
Gruneberg, S., Stubbs, M.T., Klebe, G., Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation (2002) J. Med. Chem, 45, pp. 3588-3602
Chazalette, C., Masereel, B., Rolin, S., Thiry, A., Scozzafava, A., Innocenti, A., Supuran, C.T., Bioorg. Med. Chem. Lett (2004), 14, pp. 5781-5786Thiry, A., Ledecq, M., Cecchi, A., Supuran, C.T., Wouters, J., Dogné, J.-M., Masereel, B., J. Med. Chem (2006), 49, pp. 2743-2749Thiry, A., Masereel, B., Dogné, J.-M., Supuran, C.T., Wouters, J., Michaux, C., Chem. Med. Chem. (2007), 2, pp. 1273-1280Maren, T.H., Conroy, C.W., A new class of carbonic anhydrase inhibitor (1993) J. Biol. Chem, 268, pp. 26233-26239
Temperini, C., Cecchi, A., Boyle, N.A., Scozzafava, A., Cabeza, J.E., Wentworth, P., Blackburn, G.M., Supuran, C.T., Carbonic anhydrase inhibitors. Interaction of 2-N, N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 999-1005
Fisher, S.Z., Govindasamy, L., Boyle, N., Agbandje-McKenna, M., Silverman, D.N., Blackburn, G.M., McKenna, R., X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. Acta Crystallogr (2006) Sect. F. Struct. Biol. Cryst. Commun, 62, pp. 618-622
Reed, M.J., Purohit, A., Newman, S.P., Potter, B.V.L., Steroid sulfatase: molecular biology, regulation and inhibition (2005) Endocr. Rev, 26, pp. 171-202
Stanway, S.J., Purohit, A., Woo, L.W.L., Sufi, S., Vigushin, D., Ward, R., Wilson, R., Coombs, R.C., Phase I study of STX64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor (2006) Clin. Cancer Res, 12, pp. 1585-1592
Ireson, C.R., Chander, S.K., Purohit, A., Parish, D.A., Woo, L.W.L., Potter, B.V.L., Reed, M.J., Pharmacokinetics of the non-steroidal steroid sulfatase inhibitor 667-coumate and its sequestration into red blood cells (2004) Br. J. Cancer, 91, pp. 1399-1404
Abbate, F., Winum, J.Y., Potter, B.V.L., Casini, A., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase (2004) Bioorg. Med. Chem. Lett, 14, pp. 231-234
Lloyd, M.D., Pederick, R.L., Natesh, R., Woo, L.W.L., Purohit, A., Reed, M.J., Acharya, K.R., Potter, B.V.L., Crystal structure of human carbonic anhydrase II at 1.95Å resolution in complex with 667-coumate, a novel anti-cancer agent (2005) Biochem. J, 385, pp. 715-720
Lloyd, M.D., Thiyagarajan, N., Ho, Y.T., Woo, L.W.L., Sutcliffe, O.B., Purohit, A., Reed, M.J., Potter, B.V.L., First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors (2005) Biochemistry, 44, pp. 6858-6866
Leese, M.P., Leblond, B., Smith, A., Newman, S.P., Di Fiore, A., De Simone, G., Supuran, C.T., Potter, B.V., 2-Substituted estradiol bissulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (2006) J. Med. Chem, 49, pp. 7683-7696
Leese, M.P., Jourdan, F.L., Gaukroger, K., Mahon, M.F., Newman, S.P., Foster, P.A., Stengel, C., Potter, B.V., Structure-activity relationships of C-17 cyanosubstituted estratrienes as anticancer agents (2008) J. Med. Chem, 51, pp. 1295-1308
Woo, L.W.L., Fischer, D.S., Sharland, C.M., Trusselle, M., Foster, P.A., Chander, S.K., Di Fiore, A., Potter, B.V.L., Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (2008) Mol. Cancer Ther, 7, pp. 2435-2444
Winum, J.-Y., Vullo, D., Casini, A., Montero, J.-L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors (2003) J. Med. Chem, 46, pp. 2197-2204
Elger, W., Schwarz, S., Hedden, A.M., Reddersen, G., Schneider, B., Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application (1995) J. Steroid Biochem. Mol. Biol, 55, pp. 395-403
Fischer, D.S., Woo, L.W., Mahon, M.F., Purohit, A., Reed, M.J., Potter, B.V., D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase (2003) Bioorg. Med. Chem, 11, pp. 1685-1700
Fischer, D.S., Chander, S.K., Woo, L.W., Fenton, J.C., Purohit, A., Reed, M.J., Potter, B.V., Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity (2003) J. Steroid. Biochem. Mol. Biol, 84, pp. 343-349
Sugrue, M.F., Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors (2000) Prog. Retin. Eye Res, 19, pp. 87-112
Silver, L.H., Brinzolamide Dose-Response Study Group. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt) (2000) Surv. Ophthalmol, 44 (SUPPL. 2), pp. 147-153
Colinas, P.A., Bravo, R.D., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 5086-5090
Wilkinson, B.L., Bornaghi, L.F., Houston, T.A., Innocenti, A., Vullo, D., Supuran, C.T., Poulsen, S.A., Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides (2007) Bioorg. Med. Chem. Lett, 17, pp. 987-992
Di Fiore, A., Scozzafava, A., Winum, J.Y., Montero, J.L., Pedone, C., Supuran, C.T., De Simone, G., Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 1726-1731
Winum, J.Y., Casini, A., Minzione, F., Starnotti, M., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits (2004) Bioorg. Med. Chem. Lett, 14, pp. 225-229
Shank, R.P., Gardocki, J.F., Vaught, J.L., Davis, C.B., Schupsky, J.J., Raffa, R.B., Dodgson, S.J., Maryanoff, B.E., Topiramate: preclinical evaluation of structurally novel anticonvulsant (1994) Epilepsia, 35, pp. 450-460
Edmonds Jr., H.L., Jiang, Y.D., Zhang, P.Y., Shank, R.P., Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy (1996) Life Sci., 59, pp. PL127-PL131
Stringer, J.L., A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat (2000) Epilepsy Res, 40, pp. 147-153
Sabers, A., Gram, L., Newer anticonvulsants: comparative reviewof drug interactions and adverse effects (2000) Drugs, 60, pp. 23-33
Bourgeois, B.F., Pharmacokinetics and pharmacodynamics of topiramate (2000) J. Child. Neurol., 15, pp. S27-S30
Bialer, M., Johannessen, S.I., Kupferberg, H.J., Levy, R.H., Loiseau, P., Perucca, E., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V) (2001) Epilepsy Res, 43, pp. 11-58
Gordon, A., Price, L.H., Mood stabilization and weight loss with topiramate (1999) Am. J. Psychiatry, 156, pp. 968-969
Maryanoff, B.E., Costanzo, M.J., Nortey, S.O., Greco, M.N., Shank, R.P., Schupsky, J.J., Ortegon, M.E., Vaught, J.L., Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives (1998) J. Med. Chem, 41, pp. 1315-1343
Recacha, R., Costanzo, M.J., Maryanoff, B.E., Chattopadhyay, D., Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulfamate (2002) Biochem. J, 361, pp. 437-441
Maren, T. H., Carbonic anhydrase: chemistry, physiology and inhibition (1967) Physiol. Rev, 47, pp. 595-78
Supuran, C. T., Scozzafava, A., Conway, J., Carbonic Anhydrase: Its Inhibitors and Activators (2004), pp. 1-363. , CRC Press: Boca RatonSupuran, C. T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat. Rev. Drug Discov, 7, pp. 168-181
Lehtonen, J. M., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C. T., Parkkila, A. -K., Parkkila, S., Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family (2004) J. Biol. Chem, 279, pp. 2719-2727
K hler, K., Hillebrecht, A., SchulzeWischeler, J., Innocenti, A., Heine, A., Supuran, C. T., Klebe, G., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew. Chem. Int. Ed. Engl, 46, pp. 7697-7699
Winum, J. -Y., Scozzafava, A., Montero, J. -L., Supuran, C. T., Newzinc bindingmotifs inthe design of selective carbonic anhydrase inhibitors (2006) Bioorg. Med. Chem, 6, pp. 921-936
Hilvo, M., Rafajov, M., Pastorekov, S., Pastorek, J., Parkkila, S., Expression of carbonic anhydrase IX in mouse tissues (2004) J. Histochem. Cytochem, 52, pp. 1313-1322
Kyll nen, M. S., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J. H., Shah, G. N., Sly, W. S., Kaunisto, K., Localization of carbonic anhydrase XII to the basolateral membrane of H {thorn} -secreting cells of mouse and rat kidney (2003) J. Histochem. Cytochem, 51, pp. 1217-1224
Boriack, P. A., Christianson, D. W., Kingery-Wood, J., Whitesides, G. M., Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants (1995) J. Med. Chem, 38, pp. 2286-2291
Kim, C. -Y., Chang, J. S., Doyon, J. B., Baird, T. T., Fierke, C. A., Jain, A., Christianson, D. W., Contribution of fluorine to protein-ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II (2000) J. Am. Chem. Soc, 122, pp. 12125-12134
Smith, G. M., Alexander, R. S., Christianson, D. W., McKeever, B. M., Ponticello, G. S., Springer, J. P., Randall, W. C., Habecker, C. N., Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors (1994) Protein Sci, 3, pp. 118-125
Whittington, D. A., Waheed, A., Ulmasov, B., Shah, G. N., Grubb, J. H., Sly, W. S., Christianson, D. W., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 9545-9550
Kannan, K. K., Ramanadham, M., Jones, T. A., Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I (1984) Ann. N. Y. Acad. Sci, 429, pp. 49-60
Eriksson, A. E., Jones, T. A., Liljas, A., Refined structure of human carbonic anhydrase II at 2. 0 resolution (1988) Proteins, 4, pp. 274-282
Eriksson, A. E., Liljas, A., Refined structure of bovine carbonic anhydrase III at 2. 0 resolution (1993) Proteins, 16, pp. 29-42
Duda, D. M., Tu, C., Fisher, S. Z., An, H., Yoshioka, C., Govindasamy, L., Laipis, P. J., McKenna, R., Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer (2005) Biochemistry, 44, pp. 10046-10053
H kansson, K., Carlsson, M., Svensson, L. A., Liljas, A., Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes (1992) J. Mol. Biol, 227, pp. 1192-1204
Birkh user Verlag: Basel, SwitzerlandChristianson, D. W., Fierke, C. A., Carbonic anhydrase: evolution of the zinc binding site by nature and by design (1996) Acc. Chem. Res, 29, pp. 331-339
G zel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C. T., Carbonic anhydrase inhibitors: interaction of 2- (hydrazinocarbonyl) -3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 152-158
Liljas, A., H kansson, K., Jonsson, B. H., Xue, Y., Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses (1994) Eur. J. Biochem, 219, pp. 1-10
Thiry, A., Dogn, J. M., Supuran, C. T., Masereel, B., Anticonvulsant sulfonamides/ sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action (2008) Curr. Pharm. Des, 14, pp. 661-671
Scolnick, L. R., Clements, A. M., Liao, J., Crenshaw, L., Hellberg, M., May, J., Dean, T. R., Christianson, D. W., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J. Am. Chem. Soc, 119, pp. 850-851
Mangani, S., H kansson, K., Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulfide and nitrate anions (1992) Eur. J. Biochem., 210, pp. 867-871
J nsson, B. M., H kansson, K., Liljas, A., The structure of human carbonic anhydrase II in complex with bromide and azide (1992) FEBS Lett, 322, pp. 186-190
Nair, S. K., Christianson, D. W., Crystallographic studies of azide binding to human carbonic anhydrase II (1993) Eur. J. Biochem, 213, pp. 507-515
Eriksson, A. E., Kylsten, P. M., Jones, T. A., Liljas, A., Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high pH (1983) Proteins, 4, pp. 283-293
Clare, B. W., Supuran, C. T., A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors (2006) Expert Opin. Drug Metab. Toxicol, 2, pp. 113-137
King, R. W., Burgen, A. S., Sulfonamide complexes of human carbonic anhydrases. Ultraviolet difference spectroscopy (1970) Biochim. Biophys. Acta, 207, pp. 278-285
Beasley, Y. M., Overell, B. G., Petrow, V., Stephenson, O., Some in vitro inhibitors of carbonic anhydrase (1958) J. Pharm. Pharmacol, 10, pp. 696-705
Avila, L. Z., Chu, Y. H., Blossey, E. C., Whitesides, G. M., Use of affinity capillary electrophoresis to determine kinetic and equilibrium constants for binding of arylsulfonamides to bovine carbonic anhydrase (1993) J. Med. Chem, 36, pp. 126-133
Jude, K. M., Banerjee, A. L., Haldar, M. K., Manokaran, S., Roy, B., Mallik, S., Srivastava, D. K., Christianson, D. W., Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with two-prong inhibitors reveal the molecular basis of high affinity (2006) J. Am. Chem. Soc, 128, pp. 3011-3018
Roy, B. C., Banerjee, A. L., Swanson, M., Jia, X. G., Haldar, M. K., Mallik, S., Srivastava, D. K., Two-prong inhibitors for human carbonic anhydrase II (2004) J. Am. Chem. Soc, 126, pp. 13206-13207
Doyon, J. B., Jain, A., The pattern of fluorine substitution affects binding affinity in a small library of fluoroaromatic inhibitors for carbonic anhydrase (1999) Org. Lett, 1, pp. 183-185
Taylor, P. W., King, R. W., Burgen, A. S. V., Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides (1970) Biochemistry, 9, pp. 2638-2645
Svastov, E., Hul kov, A., Rafajov, M., Zat'Ovicov, M., Gibadulinov, A., Casini, A., Cecchi, A., Pastorekov, S., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Casey, J. R., Morgan, P. E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C. T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J. Med. Chem, 47, pp. 2337-2347
Balaban, A. T., Dinculescu, A., Dorofeenko, G. N., Fischer, G. W., Koblik, A. V., Mezheritskii, V. V., Schroth, W., Pyrylium salts: syntheses, reactions and physical properties (1982), pp. 8-360. , In Advances in Heterocyclic Chemistry
Srivastava, D. K., Jude, K. M., Banerjee, A. L., Haldar, M., Manokaran, S., Kooren, J., Mallik, S., Christianson, D. W., Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II (2007) J. Am. Chem. Soc, 129, pp. 5528-5537
Kim, C. Y., Chandra, P. P., Jain, A., Christianson, D. W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J. Am. Chem. Soc, 123, pp. 9620-9627
May, J. A., Namil, A., Chen, H. H., Dantanarayana, A. P., Dupr, B., Liao, J. C., Quaternary ammonium substituted thieno [3, 2-e] -1, 2-thiazine-6-sulfonamide 1, 1-dioxides: potential membrane-impermeable inhibitors of carbonic anhydrase (2006) Bioorg. Med. Chem, 14, pp. 2052-2059
Winum, J. Y., Dogn, J. M., Casini, A., De Leval, X., Montero, J. L., Scozzafava, A., Vullo, D., Supuran, C. T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties (2005) J. Med. Chem, 48, pp. 2121-2125
Denny, W. A., Tumor-activated prodrugs. A new approach to cancer therapy (2004) Cancer Invest, 22, pp. 604-619
Saczewski, F., S awinski, J., Kornicka, A., Brzozowski, Z., Pomarnacka, E., Innocenti, A., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors (2006) Bioorg. Med. Chem. Lett, 16, pp. 4846-4851
Hanson, J., Dogn, J. M., Ghiotto, J., Moray, A. L., Kinsella, B. T., Pirotte, B., Design, synthesis, and SAR study of a series of N-alkyl-N0- [2- (aryloxy) -5-nitrobenzenesulfonyl] ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor (2007) J. Med. Chem, 50, pp. 3928-3936
FitzGerald, G. A., Patrono, C., The coxibs, selective inhibitors of cyclooxygenase-2 (2001) N. Engl. J. Med, 345, pp. 433-442
Davemport, H. W., The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide (1945) J. Biol. Chem, 158, pp. 567-571
Roblin Jr., R. O., Clapp, J. W., The preparation of heterocyclic sulfonamides (1950) J. Am. Chem. Soc, 72, pp. 4890-4892
Miller, W. H., Dessert, A. M., Roblin Jr., R. O., Heterocyclic sulfonamides as carbonic anhydrase inhibitors (1950) J. Am. Chem. Soc, 72, pp. 4893-4896
Barnish, I. T., Cross, P. E., Dickinson, R. P., Parry, M. J., Randall, M. J., Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5- (Arylthio) -, 5- (arylsulfinyl) -, and 5- (arylsulfonyl) thiophene-2-sulfonamides (1981) J. Med. Chem, 24, pp. 959-964
Maren, T. H., The development of topical carbonic anhydrase inhibitors (1995) J. Glaucoma, 4, pp. 49-62
Vaughan, J. R., Eichler, J. A., Anderson, G. W., Heterocyclic sulfonamides as carbonic anhydrase inhibitors, 2-acylamino and 2-sulfonamido-1, 3, 4-thiadiazole-5-sulfonamides (1956) J. Org. Chem, 21, pp. 700-771
Young, R. W., Wood, K. H., Vaughan, J. R., Anderson, G. W., 1, 3, 4-Thiadiazole and thiadiazolinesulfonamides as carbonic anhydrase inhibitors. Synthesis and structural studies (1956) J. Am. Chem. Soc, 78, pp. 4649-4654
Supuran, C. T., Ilies, M. A., Scozzafava, A., Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives (1998) Eur. J. Med. Chem, 33, pp. 739-752
Ilies, M. A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M. T., Pastorekova, S., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J. Med. Chem, 46, pp. 2187-2196
Kim, C. Y., Whittington, D. A., Chang, J. S., Liao, J., May, J. A., Christianson, D. W., Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV (2002) J. Med. Chem, 45, pp. 888-893
Fisher, S. Z., Govindasamy, L., Boyle, N., Agbandje-McKenna, M., Silverman, D. N., Blackburn, G. M., McKenna, R., X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. Acta Crystallogr (2006) Sect. F. Struct. Biol. Cryst. Commun, 62, pp. 618-622
Reed, M. J., Purohit, A., Newman, S. P., Potter, B. V. L., Steroid sulfatase: molecular biology, regulation and inhibition (2005) Endocr. Rev, 26, pp. 171-202
Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R., Coombs, R. C., Phase I study of STX64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor (2006) Clin. Cancer Res, 12, pp. 1585-1592
Ireson, C. R., Chander, S. K., Purohit, A., Parish, D. A., Woo, L. W. L., Potter, B. V. L., Reed, M. J., Pharmacokinetics of the non-steroidal steroid sulfatase inhibitor 667-coumate and its sequestration into red blood cells (2004) Br. J. Cancer, 91, pp. 1399-1404
Lloyd, M. D., Pederick, R. L., Natesh, R., Woo, L. W. L., Purohit, A., Reed, M. J., Acharya, K. R., Potter, B. V. L., Crystal structure of human carbonic anhydrase II at 1. 95 resolution in complex with 667-coumate, a novel anti-cancer agent (2005) Biochem. J, 385, pp. 715-720
Lloyd, M. D., Thiyagarajan, N., Ho, Y. T., Woo, L. W. L., Sutcliffe, O. B., Purohit, A., Reed, M. J., Potter, B. V. L., First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors (2005) Biochemistry, 44, pp. 6858-6866
Leese, M. P., Leblond, B., Smith, A., Newman, S. P., Di Fiore, A., De Simone, G., Supuran, C. T., Potter, B. V., 2-Substituted estradiol bissulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (2006) J. Med. Chem, 49, pp. 7683-7696
Leese, M. P., Jourdan, F. L., Gaukroger, K., Mahon, M. F., Newman, S. P., Foster, P. A., Stengel, C., Potter, B. V., Structure-activity relationships of C-17 cyanosubstituted estratrienes as anticancer agents (2008) J. Med. Chem, 51, pp. 1295-1308
Woo, L. W. L., Fischer, D. S., Sharland, C. M., Trusselle, M., Foster, P. A., Chander, S. K., Di Fiore, A., Potter, B. V. L., Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (2008) Mol. Cancer Ther, 7, pp. 2435-2444
Winum, J. -Y., Vullo, D., Casini, A., Montero, J. -L., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors (2003) J. Med. Chem, 46, pp. 2197-2204
Fischer, D. S., Woo, L. W., Mahon, M. F., Purohit, A., Reed, M. J., Potter, B. V., D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase (2003) Bioorg. Med. Chem, 11, pp. 1685-1700
Fischer, D. S., Chander, S. K., Woo, L. W., Fenton, J. C., Purohit, A., Reed, M. J., Potter, B. V., Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity (2003) J. Steroid. Biochem. Mol. Biol, 84, pp. 343-349
Sugrue, M. F., Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors (2000) Prog. Retin. Eye Res, 19, pp. 87-112
Silver, L. H., Brinzolamide Dose-Response Study Group. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt) (2000) Surv. Ophthalmol, 44 (SUPPL. 2), pp. 147-153
Colinas, P. A., Bravo, R. D., Vullo, D., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 5086-5090
Wilkinson, B. L., Bornaghi, L. F., Houston, T. A., Innocenti, A., Vullo, D., Supuran, C. T., Poulsen, S. A., Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides (2007) Bioorg. Med. Chem. Lett, 17, pp. 987-992
Winum, J. Y., Casini, A., Minzione, F., Starnotti, M., Montero, J. L., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors: N- (p-sulfamoylphenyl) -alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits (2004) Bioorg. Med. Chem. Lett, 14, pp. 225-229
Shank, R. P., Gardocki, J. F., Vaught, J. L., Davis, C. B., Schupsky, J. J., Raffa, R. B., Dodgson, S. J., Maryanoff, B. E., Topiramate: preclinical evaluation of structurally novel anticonvulsant (1994) Epilepsia, 35, pp. 450-460
Edmonds Jr., H. L., Jiang, Y. D., Zhang, P. Y., Shank, R. P., Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy (1996) Life Sci., 59, pp. PL127-PL131
Stringer, J. L., A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat (2000) Epilepsy Res, 40, pp. 147-153
Bourgeois, B. F., Pharmacokinetics and pharmacodynamics of topiramate (2000) J. Child. Neurol., 15, pp. S27-S30
Maryanoff, B. E., Costanzo, M. J., Nortey, S. O., Greco, M. N., Shank, R. P., Schupsky, J. J., Ortegon, M. E., Vaught, J. L., Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives (1998) J. Med. Chem, 41, pp. 1315-1343
Drug Des Of Zinc Enzyme Inhibitors (ISSN: 9780-4702, 9780-470275009), 2009; N/D: 73-138.
Export to BibTeX Export to EndNote
Paper type: Book Chapter,
Impact factor: 1.156, 5-year impact factor: 1.164
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84889476926&partnerID=40&md5=100abd98c45819e211516e4c1d515574
Keywords: Three-Dimensional Structures Of Hca Ii Inhibitor Complexes, X-Ray Crystallography Of Cais And Importance In Drug Design, Zinc Binding Group (zbg), Organic Scaffold And, Tails, In Potent Cai,
Affiliations:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini-CNR, Via Mezzocannone 16, 80134 Naples, Italy
Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Polo Scientifico, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence), Italy
References:
Maren, T.H., Carbonic anhydrase: chemistry, physiology and inhibition (1967) Physiol. Rev, 47, pp. 595-78
Supuran, C.T., Scozzafava, A., Conway, J., Carbonic Anhydrase: Its Inhibitors and Activators (2004), pp. 1-363. , CRC Press: Boca RatonSupuran, C.T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat. Rev. Drug Discov, 7, pp. 168-181
Lehtonen, J.M., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C.T., Parkkila, A.-K., Parkkila, S., Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family (2004) J. Biol. Chem, 279, pp. 2719-2727
Köhler, K., Hillebrecht, A., SchulzeWischeler, J., Innocenti, A., Heine, A., Supuran, C.T., Klebe, G., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew. Chem. Int. Ed. Engl, 46, pp. 7697-7699
Pastorekova, S., Parkkila, S., Pastorek, J., Supuran, C.T., Carbonic anhydrases: current state of the art, therapeutic applications and future prospects (2004) J. Enzyme Inhib. Med. Chem, 19, pp. 199-229
Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Modulation of carbonic anhydrase activity and its applications in therapy (2004) Expert Opin. Ther. Pat, 14, pp. 667-702
Winum, J.-Y., Scozzafava, A., Montero, J.-L., Supuran, C.T., Newzinc bindingmotifs inthe design of selective carbonic anhydrase inhibitors (2006) Bioorg. Med. Chem, 6, pp. 921-936
Hilvo, M., Rafajová, M., Pastoreková, S., Pastorek, J., Parkkila, S., Expression of carbonic anhydrase IX in mouse tissues (2004) J.Histochem.Cytochem, 52, pp. 1313-1322
Kaunisto, K., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J., Sly, W.S., Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification (2002) Kidney Int, 61, pp. 2111-2118
Kyllönen, M.S., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J.H., Shah, G.N., Sly, W.S., Kaunisto, K., Localization of carbonic anhydrase XII to the basolateral membrane of H{thorn}-secreting cells of mouse and rat kidney (2003) J. Histochem. Cytochem, 51, pp. 1217-1224
Menchise, V., De Simone, G., Alterio, V., Di Fiore, A., Pedone, C., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (2005) J. Med. Chem, 48, pp. 5721-5727
Weber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C.T., Scozzafava, A., Klebe, G., Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: newpharmacological opportunities due to related binding site recognition (2004) J. Med. Chem, 47, pp. 550-557
Abbate, F., Casini, A., Owa, T., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX (2004) Bioorg. Med. Chem. Lett, 14, pp. 217-223
Alterio, V., Vitale, R.M., Monti, S.M., Pedone, C., Scozzafava, A., Cecchi, A., De Simone, G., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J. Am. Chem. Soc, 128, pp. 8329-8335
Alterio, V., De Simone, G., Monti, S.M., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides-solution and crystallographic studies (2007) Bioorg. Med. Chem. Lett, 17, pp. 4201-4207
De Simone, G., Di Fiore, A., Menchise, V., Pedone, C., Antel, J., Casini, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies (2005) Bioorg. Med. Chem. Lett, 15, pp. 2315-2320
Boriack, P.A., Christianson, D.W., Kingery-Wood, J., Whitesides, G.M., Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants (1995) J. Med. Chem, 38, pp. 2286-2291
Casini, A., Antel, J., Abbate, F., Scozzafava, A., David, S., Waldeck, H., Schafer, S., Supuran, C.T., Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV (2003) Bioorg. Med. Chem. Lett, 13, pp. 841-845
Kim, C.-Y., Chang, J.S., Doyon, J.B., Baird, T.T., Fierke, C.A., Jain, A., Christianson, D.W., Contribution of fluorine to protein-ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II (2000) J. Am. Chem. Soc, 122, pp. 12125-12134
Smith, G.M., Alexander, R.S., Christianson, D.W., McKeever, B.M., Ponticello, G.S., Springer, J.P., Randall, W.C., Habecker, C.N., Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors (1994) Protein Sci, 3, pp. 118-125
Stams, T., Chen, Y., Boriack-Sjodin, P.A., Hurt, J.D., Liao, J., May, J.A., Dean, T., Christianson, D.W., Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination (1998) Protein Sci, 7, pp. 556-563
Whittington, D.A., Waheed, A., Ulmasov, B., Shah, G.N., Grubb, J.H., Sly, W.S., Christianson, D.W., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 9545-9550
Kannan, K.K., Ramanadham, M., Jones, T.A., Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I (1984) Ann. N.Y. Acad. Sci, 429, pp. 49-60
Eriksson, A.E., Jones, T.A., Liljas, A., Refined structure of human carbonic anhydrase II at 2.0 Å resolution (1988) Proteins, 4, pp. 274-282
Eriksson, A.E., Liljas, A., Refined structure of bovine carbonic anhydrase III at 2.0 Å resolution (1993) Proteins, 16, pp. 29-42
Duda, D.M., Tu, C., Fisher, S.Z., An, H., Yoshioka, C., Govindasamy, L., Laipis, P.J., McKenna, R., Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer (2005) Biochemistry, 44, pp. 10046-10053
Stams, T., Nair, S.K., Okuyama, T., Waheed, A., Sly, W.S., Christianson, D.W., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IVat 2.8 Å resolution (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 13589-13594
Di Fiore, A., Monti, S.M., Hilvo, M., Parkkila, S., Romano, V., Scaloni, A., Pedone, C., De Simone, G., Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide (2008) Proteins, 74, pp. 164-175
Håkansson, K., Carlsson, M., Svensson, L.A., Liljas, A., Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes (1992) J. Mol. Biol, 227, pp. 1192-1204
Stams, T., Christianson, D.W., X-ray crystallographic studies of mammalian carbonic anhydrase isozymes (2000), pp. 159-174. , In The Carbonic Anhydrases: New Horizons
Birkhäuser Verlag: Basel, SwitzerlandChristianson, D.W., Fierke, C.A., Carbonic anhydrase: evolution of the zinc binding site by nature and by design (1996) Acc. Chem. Res, 29, pp. 331-339
Lindskog, S., Structure and mechanism of carbonic anhydrase (1997) Pharmacol. Ther, 74, pp. 1-20
Lindskog, S., Silverman, D.W., The catalytic mechanism of mammalian carbonic anhydrases (2000), pp. 175-195. , In The Carbonic Anhydrases: New Horizons
Temperini, C., El Cheikh, K., Innocenti, A., Vullo, D., Ciattini, S., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue (2006) J. Med. Chem, 49, pp. 7024-7031
Güzel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C.T., Carbonic anhydrase inhibitors: interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 152-158
Casini, A., Abbate, F., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: Xray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamidetwo heads are better than one? Bioorg (2003) Med. Chem. Lett, 13, pp. 2759-2763
Liljas, A., Håkansson, K., Jonsson, B.H., Xue, Y., Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses (1994) Eur. J. Biochem, 219, pp. 1-10
Thiry, A., Dogné, J.M., Supuran, C.T., Masereel, B., Anticonvulsant sulfonamides/ sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action (2008) Curr. Pharm. Des, 14, pp. 661-671
Briganti, F., Mangani, S., Scozzafava, A., Vernaglione, G., Supuran, C.T., Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction? J (1999) Biol. Inorg. Chem, 4, pp. 528-536
Guerri, A., Briganti, F., Scozzafava, A., Supuran, C.T., Mangani, S., Mechanism of cyanamide hydration catalyzed by carbonic anhydrase II suggested by cryogenic X-ray diffraction (2000) Biochemistry, 39, pp. 12391-12397
Scolnick, L.R., Clements, A.M., Liao, J., Crenshaw, L., Hellberg, M., May, J., Dean, T.R., Christianson, D.W., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J. Am. Chem. Soc, 119, pp. 850-851
Mangani, S., Håkansson, K., Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulfide and nitrate anions (1992) Eur. J. Biochem., 210, pp. 867-871
Jönsson, B.M., Håkansson, K., Liljas, A., The structure of human carbonic anhydrase II in complex with bromide and azide (1992) FEBS Lett, 322, pp. 186-190
Nair, S.K., Christianson, D.W., Crystallographic studies of azide binding to human carbonic anhydrase II (1993) Eur. J. Biochem, 213, pp. 507-515
Eriksson, A.E., Kylsten, P.M., Jones, T.A., Liljas, A., Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high pH (1983) Proteins, 4, pp. 283-293
Lindahl, M., Svensson, L.A., Liljas, A., Metal poison inhibition of carbonic anhydrase (1993) Proteins, 15, pp. 177-182
Keilin, D., Mann, T., Carbonic anhydrase. Purification and nature of the enzyme (1940) Biochem. J, 34, pp. 1163-1176
Clare, B.W., Supuran, C.T., A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors (2006) Expert Opin. Drug Metab. Toxicol, 2, pp. 113-137
Temperini, C., Scozzafava, A., Supuran, C.T., Carbonic anhydrase activation and the drug design (2008) Curr. Pharm. Des, 14, pp. 708-715
King, R.W., Burgen, A.S., Sulfonamide complexes of human carbonic anhydrases. Ultraviolet difference spectroscopy (1970) Biochim. Biophys. Acta, 207, pp. 278-285
Lindahl, M., Vidgren, J., Eriksson, E., Habash, J., Harrop, S., Helliwell, J., Liljas, A., Walker, N., Crystallographic studies of carbonic anhydrase inhibition (1991), pp. 111-118. , In Carbonic Anhydrase: From Biochemistry and Genetics to Physiology and Clinical Medicine
VCH: Weinheim, GermanyAbbate, F., Supuran, C.T., Scozzafava, A., Orioli, P., Stubbs, M.T., Klebe, G., Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design (2002) J. Med. Chem, 45, pp. 3583-3587
Beasley, Y.M., Overell, B.G., Petrow, V., Stephenson, O., Some in vitro inhibitors of carbonic anhydrase (1958) J. Pharm. Pharmacol, 10, pp. 696-705
Helicon Press: Timisoara, RomaniaMincione, F., Starnotti, M., Menabuoni, L., Scozzafava, A., Casini, A., Supuran, C.T., Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl- benzenecarboxamides with strong topical antiglaucoma properties (2001) Bioorg. Med. Chem. Lett, 11, pp. 1787-1791
Jain, A., Whitesides, G.M., Alexander, R.S., Christianson, D.W., Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solutionphase and solid-state studies and their use in the development of tight-binding inhibitors (1994) J. Med. Chem, 37, pp. 2100-2105
Avila, L.Z., Chu, Y.H., Blossey, E.C., Whitesides, G.M., Use of affinity capillary electrophoresis to determine kinetic and equilibrium constants for binding of arylsulfonamides to bovine carbonic anhydrase (1993) J. Med. Chem, 36, pp. 126-133
Gao, J., Qiao, S., Whitesides, G.M., Increasing binding constants of ligands to carbonic anhydrase by using ''greasy tails'' (1995) J. Med. Chem, 38, pp. 2292-2301
Gao, J., Cheng, X., Chen, R., Sigal, G.B., Bruce, J.E., Schwartz, B.L., Hofstadler, S.A., Whiteside, G.M., Screening derivatized peptide libraries for tight binding inhibitors to carbonic anhydrase II by electrospray ionization-mass spectrometry (1996) J. Med.Chem, 39, pp. 1949-1955
Jude, K.M., Banerjee, A.L., Haldar, M.K., Manokaran, S., Roy, B., Mallik, S., Srivastava, D.K., Christianson, D.W., Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with two-prong inhibitors reveal the molecular basis of high affinity (2006) J. Am. Chem. Soc, 128, pp. 3011-3018
Roy, B.C., Banerjee, A.L., Swanson, M., Jia, X.G., Haldar, M.K., Mallik, S., Srivastava, D.K., Two-prong inhibitors for human carbonic anhydrase II (2004) J. Am. Chem. Soc, 126, pp. 13206-13207
Doyon, J.B., Jain, A., The pattern of fluorine substitution affects binding affinity in a small library of fluoroaromatic inhibitors for carbonic anhydrase (1999) Org. Lett, 1, pp. 183-185
Cappalonga Bunn, A.M., Alexander, R.S., Christianson, D.W., Mapping protein-peptide affinity: binding of peptidylsulfonamide inhibitors to human carbonic anhydrase II (1994) J. Am. Chem. Soc, 116, pp. 5063-5068
Jain, A., Huang, S.G., Whitesides, G.M., Lack of effect of the length of oligoglycine- and oligo(ethy1ene glycol)-derived para-substituents on the amnity of benzenesulfonamides for carbonic anhydrase II in solution (1994) J. Am. Chem. Soc, 116, pp. 5057-5062
Taylor, P.W., King, R.W., Burgen, A.S.V., Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides (1970) Biochemistry, 9, pp. 2638-2645
Cecchi, A., Winum, J.-Y., Innocenti, A., Vullo, D., Montero, J.-L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/ tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide (2004) Bioorg. Med. Chem. Lett, 14, pp. 5775-5780
Innocenti, A., Casini, A., Alcaro, M.C., Papini, A.M., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library (2004) J. Med. Chem, 47, pp. 5224-5229
Di Fiore, A., De Simone, G., Menchise, V., Pedone, C., Casini, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II (2005) Bioorg. Med. Chem. Lett, 15, pp. 1937-1942
Svastová, E., Hulíková, A., Rafajová, M., Zat'ovicová, M., Gibadulinová, A., Casini, A., Cecchi, A., Pastoreková, S., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Cecchi, A., Hulikova, A., Pastorek, J., Pastoreková, S., Scozzafava, A., Winum, J.Y., Montero, J.L., Supuran, C.T., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J. Med. Chem, 48, pp. 4834-4841
Pastorekova, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., Supuran, C.T., Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg. Med. Chem. Lett, 14, pp. 869-873
Scozzafava, A., Briganti, F., Ilies, M.A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes (2000) J. Med. Chem, 43, pp. 292-300
Casey, J.R., Morgan, P.E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J. Med. Chem, 47, pp. 2337-2347
Balaban, A.T., Dinculescu, A., Dorofeenko, G.N., Fischer, G.W., Koblik, A.V., Mezheritskii, V.V., Schroth, W., Pyrylium salts: syntheses, reactions and physical properties (1982), pp. 8-360. , In Advances in Heterocyclic Chemistry
Katritzky, A. R., Ed.
Academic Press: New YorkSupuran, C.T., Manole, G., Dinculescu, A., Schiketanz, A., Gheorghiu, M.D., Puscas, I., Balaban, A.T., Carbonic anhydrase inhibitors. V: Pyrylium salts in the synthesis of isozyme-specific inhibitors (1992) J. Pharm. Sci, 81, pp. 716-719
Srivastava, D.K., Jude, K.M., Banerjee, A.L., Haldar, M., Manokaran, S., Kooren, J., Mallik, S., Christianson, D.W., Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II (2007) J. Am. Chem. Soc, 129, pp. 5528-5537
Kim, C.Y., Chandra, P.P., Jain, A., Christianson, D.W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J. Am. Chem. Soc, 123, pp. 9620-9627
May, J.A., Namil, A., Chen, H.H., Dantanarayana, A.P., Dupré, B., Liao, J.C., Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: potential membrane-impermeable inhibitors of carbonic anhydrase (2006) Bioorg. Med. Chem, 14, pp. 2052-2059
Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors (2005) J. Med. Chem., 48, p. 7860
Vullo, D., Franchi, M., Gallori, E., Pastorek, J., Scozzafava, A., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (2003) Bioorg. Med. Chem. Lett, 13, pp. 1005-1009
Winum, J.Y., Dogné, J.M., Casini, A., De Leval, X., Montero, J.L., Scozzafava, A., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties (2005) J. Med. Chem, 48, pp. 2121-2125
Abbate, F., Coetzee, A., Casini, A., Ciattini, S., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride (2004) Bioorg. Med. Chem. Lett, 14, pp. 337-341
Chakravarty, S., Kannan, K.K., Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme (1994) J. Mol. Biol, 243, pp. 298-309
Vidgren, J., Liljas, A., Walker, N.P.C., Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 Å (1990) Int. J. Biol. Macromol, 12, pp. 342-344
Denny, W.A., Tumor-activated prodrugs. A new approach to cancer therapy (2004) Cancer Invest, 22, pp. 604-619
De Simone, G., Vitale, R.M., Di Fiore, A., Pedone, C., Scozzafava, A., Montero, J.-L., Winum, J.-Y., Supuran, C.T., Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J. Med. Chem, 49, pp. 5544-5551
D'Ambrosio, K., Vitale, R.M., Dogne, J.M., Masereel, B., Innocenti, A., Scozzafava, A., De Simone, G., Supuran, C.T., Carbonic anhydrase inhibitors: bioreductive nitrocontaining sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII (2008) J. Med. Chem, 51, pp. 3230-3237
Saczewski, F., Sławinski, J., Kornicka, A., Brzozowski, Z., Pomarnacka, E., Innocenti, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors (2006) Bioorg. Med. Chem. Lett, 16, pp. 4846-4851
Hanson, J., Dogné, J.M., Ghiotto, J., Moray, A.L., Kinsella, B.T., Pirotte, B., Design, synthesis, and SAR study of a series of N-alkyl-N0-[2-(aryloxy)-5-nitrobenzenesulfonyl] ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor (2007) J. Med. Chem, 50, pp. 3928-3936
FitzGerald, G.A., Patrono, C., The coxibs, selective inhibitors of cyclooxygenase-2 (2001) N. Engl. J. Med, 345, pp. 433-442
Davemport, H.W., The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide (1945) J. Biol. Chem, 158, pp. 567-571
Roblin Jr., R.O., Clapp, J.W., The preparation of heterocyclic sulfonamides (1950) J. Am. Chem. Soc, 72, pp. 4890-4892
Miller, W.H., Dessert, A.M., Roblin Jr., R.O., Heterocyclic sulfonamides as carbonic anhydrase inhibitors (1950) J. Am. Chem. Soc, 72, pp. 4893-4896
Barnish, I.T., Cross, P.E., Dickinson, R.P., Parry, M.J., Randall, M.J., Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides (1981) J. Med. Chem, 24, pp. 959-964
Maren, T.H., The development of topical carbonic anhydrase inhibitors (1995) J. Glaucoma, 4, pp. 49-62
Vaughan, J.R., Eichler, J.A., Anderson, G.W., Heterocyclic sulfonamides as carbonic anhydrase inhibitors, 2-acylamino and 2-sulfonamido-1,3,4-thiadiazole-5-sulfonamides (1956) J. Org. Chem, 21, pp. 700-771
Young, R.W., Wood, K.H., Vaughan, J.R., Anderson, G.W., 1,3,4-Thiadiazole and thiadiazolinesulfonamides as carbonic anhydrase inhibitors. Synthesis and structural studies (1956) J. Am. Chem. Soc, 78, pp. 4649-4654
Supuran, C.T., Ilies, M.A., Scozzafava, A., Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives (1998) Eur. J. Med. Chem, 33, pp. 739-752
Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/ heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action (2000) J. Med. Chem, 43, pp. 4542-4551
Ilies, M.A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M.T., Pastorekova, S., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J. Med. Chem, 46, pp. 2187-2196
Chow, K., Lai, R., Holmes, J.M., Wijono, M., Wheeler, L.A., Garst, M.E., 5-Substituted 3-thiopenesulfonamides as carbonic anhydrase inhibitors (1996) Eur. J. Med. Chem, 31, pp. 175-186
Kim, C.Y., Whittington, D.A., Chang, J.S., Liao, J., May, J.A., Christianson, D.W., Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV (2002) J. Med. Chem, 45, pp. 888-893
Nishimori, I., Minakuchi, T., Onishi, S., Vullo, D., Cecchi, A., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides (2007) Bioorg. Med. Chem, 15, pp. 7229-7236
D'Ambrosio, K., Masereel, B., Thiry, A., Scozzafava, A., Supuran, C.T., De Simone, G., Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human isoform II (2008) Chem. Med. Chem, 3, pp. 473-477
Gruneberg, S., Stubbs, M.T., Klebe, G., Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation (2002) J. Med. Chem, 45, pp. 3588-3602
Chazalette, C., Masereel, B., Rolin, S., Thiry, A., Scozzafava, A., Innocenti, A., Supuran, C.T., Bioorg. Med. Chem. Lett (2004), 14, pp. 5781-5786Thiry, A., Ledecq, M., Cecchi, A., Supuran, C.T., Wouters, J., Dogné, J.-M., Masereel, B., J. Med. Chem (2006), 49, pp. 2743-2749Thiry, A., Masereel, B., Dogné, J.-M., Supuran, C.T., Wouters, J., Michaux, C., Chem. Med. Chem. (2007), 2, pp. 1273-1280Maren, T.H., Conroy, C.W., A new class of carbonic anhydrase inhibitor (1993) J. Biol. Chem, 268, pp. 26233-26239
Temperini, C., Cecchi, A., Boyle, N.A., Scozzafava, A., Cabeza, J.E., Wentworth, P., Blackburn, G.M., Supuran, C.T., Carbonic anhydrase inhibitors. Interaction of 2-N, N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 999-1005
Fisher, S.Z., Govindasamy, L., Boyle, N., Agbandje-McKenna, M., Silverman, D.N., Blackburn, G.M., McKenna, R., X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. Acta Crystallogr (2006) Sect. F. Struct. Biol. Cryst. Commun, 62, pp. 618-622
Reed, M.J., Purohit, A., Newman, S.P., Potter, B.V.L., Steroid sulfatase: molecular biology, regulation and inhibition (2005) Endocr. Rev, 26, pp. 171-202
Stanway, S.J., Purohit, A., Woo, L.W.L., Sufi, S., Vigushin, D., Ward, R., Wilson, R., Coombs, R.C., Phase I study of STX64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor (2006) Clin. Cancer Res, 12, pp. 1585-1592
Ireson, C.R., Chander, S.K., Purohit, A., Parish, D.A., Woo, L.W.L., Potter, B.V.L., Reed, M.J., Pharmacokinetics of the non-steroidal steroid sulfatase inhibitor 667-coumate and its sequestration into red blood cells (2004) Br. J. Cancer, 91, pp. 1399-1404
Abbate, F., Winum, J.Y., Potter, B.V.L., Casini, A., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase (2004) Bioorg. Med. Chem. Lett, 14, pp. 231-234
Lloyd, M.D., Pederick, R.L., Natesh, R., Woo, L.W.L., Purohit, A., Reed, M.J., Acharya, K.R., Potter, B.V.L., Crystal structure of human carbonic anhydrase II at 1.95Å resolution in complex with 667-coumate, a novel anti-cancer agent (2005) Biochem. J, 385, pp. 715-720
Lloyd, M.D., Thiyagarajan, N., Ho, Y.T., Woo, L.W.L., Sutcliffe, O.B., Purohit, A., Reed, M.J., Potter, B.V.L., First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors (2005) Biochemistry, 44, pp. 6858-6866
Leese, M.P., Leblond, B., Smith, A., Newman, S.P., Di Fiore, A., De Simone, G., Supuran, C.T., Potter, B.V., 2-Substituted estradiol bissulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (2006) J. Med. Chem, 49, pp. 7683-7696
Leese, M.P., Jourdan, F.L., Gaukroger, K., Mahon, M.F., Newman, S.P., Foster, P.A., Stengel, C., Potter, B.V., Structure-activity relationships of C-17 cyanosubstituted estratrienes as anticancer agents (2008) J. Med. Chem, 51, pp. 1295-1308
Woo, L.W.L., Fischer, D.S., Sharland, C.M., Trusselle, M., Foster, P.A., Chander, S.K., Di Fiore, A., Potter, B.V.L., Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (2008) Mol. Cancer Ther, 7, pp. 2435-2444
Winum, J.-Y., Vullo, D., Casini, A., Montero, J.-L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors (2003) J. Med. Chem, 46, pp. 2197-2204
Elger, W., Schwarz, S., Hedden, A.M., Reddersen, G., Schneider, B., Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application (1995) J. Steroid Biochem. Mol. Biol, 55, pp. 395-403
Fischer, D.S., Woo, L.W., Mahon, M.F., Purohit, A., Reed, M.J., Potter, B.V., D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase (2003) Bioorg. Med. Chem, 11, pp. 1685-1700
Fischer, D.S., Chander, S.K., Woo, L.W., Fenton, J.C., Purohit, A., Reed, M.J., Potter, B.V., Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity (2003) J. Steroid. Biochem. Mol. Biol, 84, pp. 343-349
Sugrue, M.F., Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors (2000) Prog. Retin. Eye Res, 19, pp. 87-112
Silver, L.H., Brinzolamide Dose-Response Study Group. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt) (2000) Surv. Ophthalmol, 44 (SUPPL. 2), pp. 147-153
Colinas, P.A., Bravo, R.D., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 5086-5090
Wilkinson, B.L., Bornaghi, L.F., Houston, T.A., Innocenti, A., Vullo, D., Supuran, C.T., Poulsen, S.A., Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides (2007) Bioorg. Med. Chem. Lett, 17, pp. 987-992
Di Fiore, A., Scozzafava, A., Winum, J.Y., Montero, J.L., Pedone, C., Supuran, C.T., De Simone, G., Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 1726-1731
Winum, J.Y., Casini, A., Minzione, F., Starnotti, M., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits (2004) Bioorg. Med. Chem. Lett, 14, pp. 225-229
Shank, R.P., Gardocki, J.F., Vaught, J.L., Davis, C.B., Schupsky, J.J., Raffa, R.B., Dodgson, S.J., Maryanoff, B.E., Topiramate: preclinical evaluation of structurally novel anticonvulsant (1994) Epilepsia, 35, pp. 450-460
Edmonds Jr., H.L., Jiang, Y.D., Zhang, P.Y., Shank, R.P., Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy (1996) Life Sci., 59, pp. PL127-PL131
Stringer, J.L., A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat (2000) Epilepsy Res, 40, pp. 147-153
Sabers, A., Gram, L., Newer anticonvulsants: comparative reviewof drug interactions and adverse effects (2000) Drugs, 60, pp. 23-33
Bourgeois, B.F., Pharmacokinetics and pharmacodynamics of topiramate (2000) J. Child. Neurol., 15, pp. S27-S30
Bialer, M., Johannessen, S.I., Kupferberg, H.J., Levy, R.H., Loiseau, P., Perucca, E., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V) (2001) Epilepsy Res, 43, pp. 11-58
Gordon, A., Price, L.H., Mood stabilization and weight loss with topiramate (1999) Am. J. Psychiatry, 156, pp. 968-969
Maryanoff, B.E., Costanzo, M.J., Nortey, S.O., Greco, M.N., Shank, R.P., Schupsky, J.J., Ortegon, M.E., Vaught, J.L., Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives (1998) J. Med. Chem, 41, pp. 1315-1343
Recacha, R., Costanzo, M.J., Maryanoff, B.E., Chattopadhyay, D., Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulfamate (2002) Biochem. J, 361, pp. 437-441
Maren, T. H., Carbonic anhydrase: chemistry, physiology and inhibition (1967) Physiol. Rev, 47, pp. 595-78
Supuran, C. T., Scozzafava, A., Conway, J., Carbonic Anhydrase: Its Inhibitors and Activators (2004), pp. 1-363. , CRC Press: Boca RatonSupuran, C. T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat. Rev. Drug Discov, 7, pp. 168-181
Lehtonen, J. M., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C. T., Parkkila, A. -K., Parkkila, S., Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family (2004) J. Biol. Chem, 279, pp. 2719-2727
K hler, K., Hillebrecht, A., SchulzeWischeler, J., Innocenti, A., Heine, A., Supuran, C. T., Klebe, G., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew. Chem. Int. Ed. Engl, 46, pp. 7697-7699
Winum, J. -Y., Scozzafava, A., Montero, J. -L., Supuran, C. T., Newzinc bindingmotifs inthe design of selective carbonic anhydrase inhibitors (2006) Bioorg. Med. Chem, 6, pp. 921-936
Hilvo, M., Rafajov, M., Pastorekov, S., Pastorek, J., Parkkila, S., Expression of carbonic anhydrase IX in mouse tissues (2004) J. Histochem. Cytochem, 52, pp. 1313-1322
Kyll nen, M. S., Parkkila, S., Rajaniemi, H., Waheed, A., Grubb, J. H., Shah, G. N., Sly, W. S., Kaunisto, K., Localization of carbonic anhydrase XII to the basolateral membrane of H {thorn} -secreting cells of mouse and rat kidney (2003) J. Histochem. Cytochem, 51, pp. 1217-1224
Boriack, P. A., Christianson, D. W., Kingery-Wood, J., Whitesides, G. M., Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants (1995) J. Med. Chem, 38, pp. 2286-2291
Kim, C. -Y., Chang, J. S., Doyon, J. B., Baird, T. T., Fierke, C. A., Jain, A., Christianson, D. W., Contribution of fluorine to protein-ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II (2000) J. Am. Chem. Soc, 122, pp. 12125-12134
Smith, G. M., Alexander, R. S., Christianson, D. W., McKeever, B. M., Ponticello, G. S., Springer, J. P., Randall, W. C., Habecker, C. N., Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors (1994) Protein Sci, 3, pp. 118-125
Whittington, D. A., Waheed, A., Ulmasov, B., Shah, G. N., Grubb, J. H., Sly, W. S., Christianson, D. W., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 9545-9550
Kannan, K. K., Ramanadham, M., Jones, T. A., Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I (1984) Ann. N. Y. Acad. Sci, 429, pp. 49-60
Eriksson, A. E., Jones, T. A., Liljas, A., Refined structure of human carbonic anhydrase II at 2. 0 resolution (1988) Proteins, 4, pp. 274-282
Eriksson, A. E., Liljas, A., Refined structure of bovine carbonic anhydrase III at 2. 0 resolution (1993) Proteins, 16, pp. 29-42
Duda, D. M., Tu, C., Fisher, S. Z., An, H., Yoshioka, C., Govindasamy, L., Laipis, P. J., McKenna, R., Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer (2005) Biochemistry, 44, pp. 10046-10053
H kansson, K., Carlsson, M., Svensson, L. A., Liljas, A., Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes (1992) J. Mol. Biol, 227, pp. 1192-1204
Birkh user Verlag: Basel, SwitzerlandChristianson, D. W., Fierke, C. A., Carbonic anhydrase: evolution of the zinc binding site by nature and by design (1996) Acc. Chem. Res, 29, pp. 331-339
G zel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C. T., Carbonic anhydrase inhibitors: interaction of 2- (hydrazinocarbonyl) -3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg. Med. Chem. Lett, 18, pp. 152-158
Liljas, A., H kansson, K., Jonsson, B. H., Xue, Y., Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses (1994) Eur. J. Biochem, 219, pp. 1-10
Thiry, A., Dogn, J. M., Supuran, C. T., Masereel, B., Anticonvulsant sulfonamides/ sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action (2008) Curr. Pharm. Des, 14, pp. 661-671
Scolnick, L. R., Clements, A. M., Liao, J., Crenshaw, L., Hellberg, M., May, J., Dean, T. R., Christianson, D. W., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J. Am. Chem. Soc, 119, pp. 850-851
Mangani, S., H kansson, K., Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulfide and nitrate anions (1992) Eur. J. Biochem., 210, pp. 867-871
J nsson, B. M., H kansson, K., Liljas, A., The structure of human carbonic anhydrase II in complex with bromide and azide (1992) FEBS Lett, 322, pp. 186-190
Nair, S. K., Christianson, D. W., Crystallographic studies of azide binding to human carbonic anhydrase II (1993) Eur. J. Biochem, 213, pp. 507-515
Eriksson, A. E., Kylsten, P. M., Jones, T. A., Liljas, A., Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high pH (1983) Proteins, 4, pp. 283-293
Clare, B. W., Supuran, C. T., A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors (2006) Expert Opin. Drug Metab. Toxicol, 2, pp. 113-137
King, R. W., Burgen, A. S., Sulfonamide complexes of human carbonic anhydrases. Ultraviolet difference spectroscopy (1970) Biochim. Biophys. Acta, 207, pp. 278-285
Beasley, Y. M., Overell, B. G., Petrow, V., Stephenson, O., Some in vitro inhibitors of carbonic anhydrase (1958) J. Pharm. Pharmacol, 10, pp. 696-705
Avila, L. Z., Chu, Y. H., Blossey, E. C., Whitesides, G. M., Use of affinity capillary electrophoresis to determine kinetic and equilibrium constants for binding of arylsulfonamides to bovine carbonic anhydrase (1993) J. Med. Chem, 36, pp. 126-133
Jude, K. M., Banerjee, A. L., Haldar, M. K., Manokaran, S., Roy, B., Mallik, S., Srivastava, D. K., Christianson, D. W., Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with two-prong inhibitors reveal the molecular basis of high affinity (2006) J. Am. Chem. Soc, 128, pp. 3011-3018
Roy, B. C., Banerjee, A. L., Swanson, M., Jia, X. G., Haldar, M. K., Mallik, S., Srivastava, D. K., Two-prong inhibitors for human carbonic anhydrase II (2004) J. Am. Chem. Soc, 126, pp. 13206-13207
Doyon, J. B., Jain, A., The pattern of fluorine substitution affects binding affinity in a small library of fluoroaromatic inhibitors for carbonic anhydrase (1999) Org. Lett, 1, pp. 183-185
Taylor, P. W., King, R. W., Burgen, A. S. V., Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides (1970) Biochemistry, 9, pp. 2638-2645
Svastov, E., Hul kov, A., Rafajov, M., Zat'Ovicov, M., Gibadulinov, A., Casini, A., Cecchi, A., Pastorekov, S., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Casey, J. R., Morgan, P. E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C. T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J. Med. Chem, 47, pp. 2337-2347
Balaban, A. T., Dinculescu, A., Dorofeenko, G. N., Fischer, G. W., Koblik, A. V., Mezheritskii, V. V., Schroth, W., Pyrylium salts: syntheses, reactions and physical properties (1982), pp. 8-360. , In Advances in Heterocyclic Chemistry
Srivastava, D. K., Jude, K. M., Banerjee, A. L., Haldar, M., Manokaran, S., Kooren, J., Mallik, S., Christianson, D. W., Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II (2007) J. Am. Chem. Soc, 129, pp. 5528-5537
Kim, C. Y., Chandra, P. P., Jain, A., Christianson, D. W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J. Am. Chem. Soc, 123, pp. 9620-9627
May, J. A., Namil, A., Chen, H. H., Dantanarayana, A. P., Dupr, B., Liao, J. C., Quaternary ammonium substituted thieno [3, 2-e] -1, 2-thiazine-6-sulfonamide 1, 1-dioxides: potential membrane-impermeable inhibitors of carbonic anhydrase (2006) Bioorg. Med. Chem, 14, pp. 2052-2059
Winum, J. Y., Dogn, J. M., Casini, A., De Leval, X., Montero, J. L., Scozzafava, A., Vullo, D., Supuran, C. T., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties (2005) J. Med. Chem, 48, pp. 2121-2125
Denny, W. A., Tumor-activated prodrugs. A new approach to cancer therapy (2004) Cancer Invest, 22, pp. 604-619
Saczewski, F., S awinski, J., Kornicka, A., Brzozowski, Z., Pomarnacka, E., Innocenti, A., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors (2006) Bioorg. Med. Chem. Lett, 16, pp. 4846-4851
Hanson, J., Dogn, J. M., Ghiotto, J., Moray, A. L., Kinsella, B. T., Pirotte, B., Design, synthesis, and SAR study of a series of N-alkyl-N0- [2- (aryloxy) -5-nitrobenzenesulfonyl] ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor (2007) J. Med. Chem, 50, pp. 3928-3936
FitzGerald, G. A., Patrono, C., The coxibs, selective inhibitors of cyclooxygenase-2 (2001) N. Engl. J. Med, 345, pp. 433-442
Davemport, H. W., The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide (1945) J. Biol. Chem, 158, pp. 567-571
Roblin Jr., R. O., Clapp, J. W., The preparation of heterocyclic sulfonamides (1950) J. Am. Chem. Soc, 72, pp. 4890-4892
Miller, W. H., Dessert, A. M., Roblin Jr., R. O., Heterocyclic sulfonamides as carbonic anhydrase inhibitors (1950) J. Am. Chem. Soc, 72, pp. 4893-4896
Barnish, I. T., Cross, P. E., Dickinson, R. P., Parry, M. J., Randall, M. J., Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5- (Arylthio) -, 5- (arylsulfinyl) -, and 5- (arylsulfonyl) thiophene-2-sulfonamides (1981) J. Med. Chem, 24, pp. 959-964
Maren, T. H., The development of topical carbonic anhydrase inhibitors (1995) J. Glaucoma, 4, pp. 49-62
Vaughan, J. R., Eichler, J. A., Anderson, G. W., Heterocyclic sulfonamides as carbonic anhydrase inhibitors, 2-acylamino and 2-sulfonamido-1, 3, 4-thiadiazole-5-sulfonamides (1956) J. Org. Chem, 21, pp. 700-771
Young, R. W., Wood, K. H., Vaughan, J. R., Anderson, G. W., 1, 3, 4-Thiadiazole and thiadiazolinesulfonamides as carbonic anhydrase inhibitors. Synthesis and structural studies (1956) J. Am. Chem. Soc, 78, pp. 4649-4654
Supuran, C. T., Ilies, M. A., Scozzafava, A., Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives (1998) Eur. J. Med. Chem, 33, pp. 739-752
Ilies, M. A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M. T., Pastorekova, S., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J. Med. Chem, 46, pp. 2187-2196
Kim, C. Y., Whittington, D. A., Chang, J. S., Liao, J., May, J. A., Christianson, D. W., Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV (2002) J. Med. Chem, 45, pp. 888-893
Fisher, S. Z., Govindasamy, L., Boyle, N., Agbandje-McKenna, M., Silverman, D. N., Blackburn, G. M., McKenna, R., X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. Acta Crystallogr (2006) Sect. F. Struct. Biol. Cryst. Commun, 62, pp. 618-622
Reed, M. J., Purohit, A., Newman, S. P., Potter, B. V. L., Steroid sulfatase: molecular biology, regulation and inhibition (2005) Endocr. Rev, 26, pp. 171-202
Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R., Coombs, R. C., Phase I study of STX64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor (2006) Clin. Cancer Res, 12, pp. 1585-1592
Ireson, C. R., Chander, S. K., Purohit, A., Parish, D. A., Woo, L. W. L., Potter, B. V. L., Reed, M. J., Pharmacokinetics of the non-steroidal steroid sulfatase inhibitor 667-coumate and its sequestration into red blood cells (2004) Br. J. Cancer, 91, pp. 1399-1404
Lloyd, M. D., Pederick, R. L., Natesh, R., Woo, L. W. L., Purohit, A., Reed, M. J., Acharya, K. R., Potter, B. V. L., Crystal structure of human carbonic anhydrase II at 1. 95 resolution in complex with 667-coumate, a novel anti-cancer agent (2005) Biochem. J, 385, pp. 715-720
Lloyd, M. D., Thiyagarajan, N., Ho, Y. T., Woo, L. W. L., Sutcliffe, O. B., Purohit, A., Reed, M. J., Potter, B. V. L., First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors (2005) Biochemistry, 44, pp. 6858-6866
Leese, M. P., Leblond, B., Smith, A., Newman, S. P., Di Fiore, A., De Simone, G., Supuran, C. T., Potter, B. V., 2-Substituted estradiol bissulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (2006) J. Med. Chem, 49, pp. 7683-7696
Leese, M. P., Jourdan, F. L., Gaukroger, K., Mahon, M. F., Newman, S. P., Foster, P. A., Stengel, C., Potter, B. V., Structure-activity relationships of C-17 cyanosubstituted estratrienes as anticancer agents (2008) J. Med. Chem, 51, pp. 1295-1308
Woo, L. W. L., Fischer, D. S., Sharland, C. M., Trusselle, M., Foster, P. A., Chander, S. K., Di Fiore, A., Potter, B. V. L., Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (2008) Mol. Cancer Ther, 7, pp. 2435-2444
Winum, J. -Y., Vullo, D., Casini, A., Montero, J. -L., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors (2003) J. Med. Chem, 46, pp. 2197-2204
Fischer, D. S., Woo, L. W., Mahon, M. F., Purohit, A., Reed, M. J., Potter, B. V., D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase (2003) Bioorg. Med. Chem, 11, pp. 1685-1700
Fischer, D. S., Chander, S. K., Woo, L. W., Fenton, J. C., Purohit, A., Reed, M. J., Potter, B. V., Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity (2003) J. Steroid. Biochem. Mol. Biol, 84, pp. 343-349
Sugrue, M. F., Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors (2000) Prog. Retin. Eye Res, 19, pp. 87-112
Silver, L. H., Brinzolamide Dose-Response Study Group. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt) (2000) Surv. Ophthalmol, 44 (SUPPL. 2), pp. 147-153
Colinas, P. A., Bravo, R. D., Vullo, D., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg. Med. Chem. Lett, 17, pp. 5086-5090
Wilkinson, B. L., Bornaghi, L. F., Houston, T. A., Innocenti, A., Vullo, D., Supuran, C. T., Poulsen, S. A., Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides (2007) Bioorg. Med. Chem. Lett, 17, pp. 987-992
Winum, J. Y., Casini, A., Minzione, F., Starnotti, M., Montero, J. L., Scozzafava, A., Supuran, C. T., Carbonic anhydrase inhibitors: N- (p-sulfamoylphenyl) -alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits (2004) Bioorg. Med. Chem. Lett, 14, pp. 225-229
Shank, R. P., Gardocki, J. F., Vaught, J. L., Davis, C. B., Schupsky, J. J., Raffa, R. B., Dodgson, S. J., Maryanoff, B. E., Topiramate: preclinical evaluation of structurally novel anticonvulsant (1994) Epilepsia, 35, pp. 450-460
Edmonds Jr., H. L., Jiang, Y. D., Zhang, P. Y., Shank, R. P., Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy (1996) Life Sci., 59, pp. PL127-PL131
Stringer, J. L., A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat (2000) Epilepsy Res, 40, pp. 147-153
Bourgeois, B. F., Pharmacokinetics and pharmacodynamics of topiramate (2000) J. Child. Neurol., 15, pp. S27-S30
Maryanoff, B. E., Costanzo, M. J., Nortey, S. O., Greco, M. N., Shank, R. P., Schupsky, J. J., Ortegon, M. E., Vaught, J. L., Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives (1998) J. Med. Chem, 41, pp. 1315-1343
X-Ray Crystallography of Carbonic Anhydrase Inhibitors and Its Importance in Drug Design
Not available.
Not available.
X-Ray Crystallography of Carbonic Anhydrase Inhibitors and Its Importance in Drug Design
No results. |
426 views. Last view on Friday 03 February 2023, 7:10:48
ibb.cnr.it
